$MICR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MICRON SOLUTIONS INC /DE/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MICRON SOLUTIONS INC /DE/. Get notifications about new insider transactions in MICRON SOLUTIONS INC /DE/ for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20 2014 | HRT | ARRHYTHMIA RESEARC ... | Emma Salvatore Jr | PRESIDENT and CEO | Sell | S | 7.33 | 200 | 1,466 | 10,627 | 10.8 K to 10.6 K (-1.85 %) |
| Aug 20 2014 | HRT | ARRHYTHMIA RESEARC ... | Emma Salvatore Jr | PRESIDENT and CEO | Sell | S | 7.29 | 100 | 729 | 10,827 | 10.9 K to 10.8 K (-0.92 %) |
| Aug 20 2014 | HRT | ARRHYTHMIA RESEARC ... | Emma Salvatore Jr | PRESIDENT and CEO | Sell | S | 7.25 | 73 | 529 | 10,927 | 11 K to 10.9 K (-0.66 %) |
| Aug 20 2014 | HRT | ARRHYTHMIA RESEARC ... | Emma Salvatore Jr | PRESIDENT and CEO | Sell | S | 7.24 | 600 | 4,341 | 11,000 | 11.6 K to 11 K (-5.17 %) |
| Aug 20 2014 | HRT | ARRHYTHMIA RESEARC ... | Emma Salvatore Jr | PRESIDENT and CEO | Sell | S | 7.23 | 1,400 | 10,122 | 11,600 | 13 K to 11.6 K (-10.77 %) |
| Aug 20 2014 | HRT | ARRHYTHMIA RESEARC ... | Emma Salvatore Jr | PRESIDENT and CEO | Grant | A | 2.58 | 3,000 | 7,740 | 13,000 | 10 K to 13 K (+30.00 %) |
| Aug 20 2014 | HRT | ARRHYTHMIA RESEARC ... | Emma Salvatore Jr | PRESIDENT and CEO | Grant | A | 3.41 | 4,000 | 13,640 | 10,000 | 6 K to 10 K (+66.67 %) |
| Aug 20 2014 | HRT | ARRHYTHMIA RESEARC ... | Emma Salvatore Jr | PRESIDENT and CEO | Grant | A | 5.73 | 1,600 | 9,168 | 6,000 | 4.4 K to 6 K (+36.36 %) |
| Aug 20 2014 | HRT | ARRHYTHMIA RESEARC ... | Emma Salvatore Jr | PRESIDENT and CEO | Grant | A | 5.73 | 4,400 | 25,212 | 4,400 | 0 to 4.4 K |
| Aug 14 2014 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Sell | S | 7.30 | 5,000 | 36,500 | 100,043 | 105 K to 100 K (-4.76 %) |
| Jan 10 2014 | HRT | ARRHYTHMIA RESEARC ... | Chambers Medical Foundation | 10% Owner | Option Exercise | P | 3.51 | 20,000 | 70,200 | 20,000 | |
| Dec 23 2013 | HRT | ARRHYTHMIA RESEARC ... | MARINOS E P | Director | Option Exercise | P | 3.51 | 10,000 | 35,100 | 10,000 | |
| Dec 19 2013 | HRT | ARRHYTHMIA RESEARC ... | Welch Derek Thomas | Principal Financial ... | Option Exercise | A | 3.67 | 10,000 | 36,700 | 10,000 | |
| Dec 04 2013 | HRT | ARRHYTHMIA RESEARC ... | MARINOS E P | Director | Grant | A | 0.00 | 6,000 | 0 | 57,948 | 51.9 K to 57.9 K (+11.55 %) |
| Dec 04 2013 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Grant | A | 0.00 | 6,000 | 0 | 105,043 | 99 K to 105 K (+6.06 %) |
| Dec 04 2013 | HRT | ARRHYTHMIA RESEARC ... | WALTER PAUL | Director | Grant | A | 0.00 | 6,000 | 0 | 68,055 | 62.1 K to 68.1 K (+9.67 %) |
| Dec 19 2012 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Interim CEO | Buy | P | 2.60 | 3,329 | 8,655 | 15,500 | 12.2 K to 15.5 K (+27.35 %) |
| Dec 19 2012 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Interim CEO | Buy | P | 2.65 | 1,625 | 4,306 | 12,171 | 10.5 K to 12.2 K (+15.41 %) |
| Dec 19 2012 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Interim CEO | Buy | P | 2.65 | 46 | 122 | 10,546 | 10.5 K to 10.5 K (+0.44 %) |
| Dec 10 2012 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Interim CEO | Buy | P | 2.60 | 4,000 | 10,400 | 10,500 | 6.5 K to 10.5 K (+61.54 %) |
| Dec 10 2012 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Interim CEO | Buy | P | 2.59 | 300 | 777 | 6,500 | 6.2 K to 6.5 K (+4.84 %) |
| Dec 10 2012 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Interim CEO | Buy | P | 2.40 | 600 | 1,440 | 6,200 | 5.6 K to 6.2 K (+10.71 %) |
| Dec 10 2012 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Interim CEO | Buy | P | 2.39 | 100 | 239 | 5,600 | 5.5 K to 5.6 K (+1.82 %) |
| Dec 06 2012 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Grant | A | 2.58 | 1,600 | 4,128 | 23,600 | 22 K to 23.6 K (+7.27 %) |
| Dec 06 2012 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Grant | A | 2.58 | 100 | 258 | 22,000 | 21.9 K to 22 K (+0.46 %) |
| Dec 06 2012 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Grant | A | 2.57 | 300 | 771 | 21,900 | 21.6 K to 21.9 K (+1.39 %) |
| Dec 06 2012 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Grant | A | 2.55 | 1,887 | 4,812 | 21,600 | 19.7 K to 21.6 K (+9.57 %) |
| Dec 06 2012 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Grant | A | 2.53 | 1,205 | 3,049 | 19,713 | 18.5 K to 19.7 K (+6.51 %) |
| Dec 06 2012 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Grant | A | 2.51 | 200 | 502 | 18,508 | 18.3 K to 18.5 K (+1.09 %) |
| Dec 06 2012 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Grant | A | 2.50 | 20 | 50 | 18,308 | 18.3 K to 18.3 K (+0.11 %) |
| Dec 06 2012 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Grant | A | 2.47 | 100 | 247 | 18,288 | 18.2 K to 18.3 K (+0.55 %) |
| Dec 06 2012 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Grant | A | 2.46 | 100 | 246 | 18,188 | 18.1 K to 18.2 K (+0.55 %) |
| Dec 06 2012 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Grant | A | 2.25 | 488 | 1,098 | 18,088 | 17.6 K to 18.1 K (+2.77 %) |
| Aug 10 2012 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Gift | G | 0.00 | 83,010 | 0 | 99,043 | 16 K to 99 K (+517.74 %) |
| Feb 14 2012 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Director | Buy | P | 4.85 | 300 | 1,455 | 1,000 | 700 to 1,000 (+42.86 %) |
| Dec 15 2011 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Director | Buy | P | 3.20 | 500 | 1,600 | 3,500 | 3 K to 3.5 K (+16.67 %) |
| Dec 12 2011 | HRT | ARRHYTHMIA RESEARC ... | MULDOON PATRICK L | Director | Buy | P | 3.71 | 2,595 | 9,627 | 2,695 | 100 to 2.7 K (+2,595.00 %) |
| Dec 12 2011 | HRT | ARRHYTHMIA RESEARC ... | MULDOON PATRICK L | Director | Buy | P | 3.67 | 100 | 367 | 100 | 0 to 100 |
| Nov 30 2011 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Director | Buy | P | 3.39 | 200 | 678 | 3,000 | 2.8 K to 3 K (+7.14 %) |
| Nov 30 2011 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Director | Buy | P | 3.38 | 100 | 338 | 2,800 | 2.7 K to 2.8 K (+3.70 %) |
| Nov 30 2011 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Director | Buy | P | 3.40 | 2,000 | 6,800 | 2,700 | 700 to 2.7 K (+285.71 %) |
| Sep 19 2011 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | President & CEO | Buy | P | 3.92 | 3,061 | 11,999 | 20,000 | 16.9 K to 20 K (+18.07 %) |
| Sep 19 2011 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | President & CEO | Buy | P | 3.77 | 100 | 377 | 16,939 | 16.8 K to 16.9 K (+0.59 %) |
| Sep 19 2011 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | President & CEO | Buy | P | 3.75 | 1,839 | 6,896 | 16,839 | 15 K to 16.8 K (+12.26 %) |
| Sep 15 2011 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Director | Buy | P | 3.60 | 900 | 3,240 | 2,400 | 1.5 K to 2.4 K (+60.00 %) |
| Sep 15 2011 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Director | Buy | P | 3.60 | 100 | 360 | 1,500 | 1.4 K to 1.5 K (+7.14 %) |
| Sep 15 2011 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Director | Buy | P | 3.55 | 100 | 355 | 1,400 | 1.3 K to 1.4 K (+7.69 %) |
| Sep 15 2011 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Director | Buy | P | 3.55 | 600 | 2,130 | 1,300 | 700 to 1.3 K (+85.71 %) |
| Aug 31 2011 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Executive VP & CFO | Buy | P | 3.80 | 1,100 | 4,179 | 16,200 | 15.1 K to 16.2 K (+7.28 %) |
| Aug 31 2011 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Executive VP & CFO | Buy | P | 3.79 | 200 | 758 | 15,100 | 14.9 K to 15.1 K (+1.34 %) |
| Aug 31 2011 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Executive VP & CFO | Buy | P | 3.79 | 100 | 379 | 14,900 | 14.8 K to 14.9 K (+0.68 %) |
| Aug 31 2011 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Executive VP & CFO | Buy | P | 3.75 | 4,800 | 18,000 | 14,800 | 10 K to 14.8 K (+48.00 %) |
| Aug 31 2011 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Executive VP & CFO | Buy | P | 3.62 | 500 | 1,810 | 17,600 | 17.1 K to 17.6 K (+2.92 %) |
| Aug 31 2011 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Executive VP & CFO | Buy | P | 3.74 | 200 | 748 | 17,100 | 16.9 K to 17.1 K (+1.18 %) |
| Aug 31 2011 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Executive VP & CFO | Buy | P | 3.75 | 700 | 2,625 | 16,900 | 16.2 K to 16.9 K (+4.32 %) |
| Jun 08 2011 | HRT | ARRHYTHMIA RESEARC ... | MULDOON PATRICK L | Director | Option Exercise | A | 5.73 | 10,000 | 57,300 | 10,000 | |
| Jun 08 2011 | HRT | ARRHYTHMIA RESEARC ... | Gunter Michael S | Director | Option Exercise | A | 5.73 | 10,000 | 57,300 | 10,000 | |
| Jun 08 2011 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Option Exercise | A | 5.73 | 10,000 | 57,300 | 40,500 | |
| Jun 08 2011 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Option Exercise | A | 9.86 | 10,000 | 98,600 | 30,500 | |
| Jun 08 2011 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | President and CEO | Option Exercise | A | 5.73 | 10,000 | 57,300 | 37,000 | |
| Jun 08 2011 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | President and CEO | Option Exercise | A | 9.86 | 10,000 | 98,600 | 27,000 | |
| Jun 08 2011 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Option Exercise | A | 5.73 | 10,000 | 57,300 | 47,500 | |
| Jun 08 2011 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Option Exercise | A | 9.86 | 10,000 | 98,600 | 37,500 | |
| Jun 08 2011 | HRT | ARRHYTHMIA RESEARC ... | TABIN JULIUS | Director | Option Exercise | A | 5.73 | 10,000 | 57,300 | 47,500 | |
| Jun 08 2011 | HRT | ARRHYTHMIA RESEARC ... | TABIN JULIUS | Director | Option Exercise | A | 9.86 | 10,000 | 98,600 | 37,500 | |
| Jun 08 2011 | HRT | ARRHYTHMIA RESEARC ... | WALTER PAUL | Director | Option Exercise | A | 5.73 | 10,000 | 57,300 | 47,500 | |
| Jun 08 2011 | HRT | ARRHYTHMIA RESEARC ... | WALTER PAUL | Director | Option Exercise | A | 9.86 | 10,000 | 98,600 | 37,500 | |
| Jun 08 2011 | HRT | ARRHYTHMIA RESEARC ... | MARINOS E P | Director | Option Exercise | A | 5.73 | 10,000 | 57,300 | 47,500 | |
| Jun 08 2011 | HRT | ARRHYTHMIA RESEARC ... | MARINOS E P | Director | Option Exercise | A | 9.86 | 10,000 | 98,600 | 37,500 | |
| Jan 06 2010 | HRT | ARRHYTHMIA RESEARC ... | WALTER PAUL | Director | Option Exercise | A | 3.41 | 7,500 | 25,575 | 27,500 | |
| Jan 06 2010 | HRT | ARRHYTHMIA RESEARC ... | TABIN JULIUS | Director | Option Exercise | A | 3.41 | 7,500 | 25,575 | 27,500 | |
| Jan 06 2010 | HRT | ARRHYTHMIA RESEARC ... | MARINOS E P | Director | Option Exercise | A | 3.41 | 7,500 | 25,575 | 27,500 | |
| Jan 06 2010 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | President and CEO | Option Exercise | A | 3.41 | 7,500 | 25,575 | 17,000 | |
| Jan 06 2010 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Option Exercise | A | 3.41 | 7,500 | 25,575 | 17,500 | |
| Jan 06 2010 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Option Exercise | A | 3.41 | 5,000 | 17,050 | 20,500 | |
| Sep 17 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.07 | 600 | 1,841 | 10,000 | 9.4 K to 10 K (+6.38 %) |
| Sep 17 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.07 | 900 | 2,759 | 9,400 | 8.5 K to 9.4 K (+10.59 %) |
| Sep 17 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.02 | 286 | 864 | 8,500 | 8.2 K to 8.5 K (+3.48 %) |
| Sep 17 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.07 | 414 | 1,271 | 8,214 | 7.8 K to 8.2 K (+5.31 %) |
| Sep 17 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.10 | 100 | 310 | 7,800 | 7.7 K to 7.8 K (+1.30 %) |
| Sep 17 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.11 | 300 | 933 | 7,700 | 7.4 K to 7.7 K (+4.05 %) |
| Sep 17 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.12 | 200 | 624 | 7,400 | 7.2 K to 7.4 K (+2.78 %) |
| Sep 17 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.13 | 300 | 939 | 7,200 | 6.9 K to 7.2 K (+4.35 %) |
| Sep 17 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.15 | 1,900 | 5,985 | 6,900 | 5 K to 6.9 K (+38.00 %) |
| Aug 12 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.39 | 163 | 552 | 5,000 | 4.8 K to 5 K (+3.37 %) |
| Aug 12 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.34 | 400 | 1,336 | 4,837 | 4.4 K to 4.8 K (+9.02 %) |
| Aug 12 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.40 | 200 | 680 | 4,437 | 4.2 K to 4.4 K (+4.72 %) |
| Aug 12 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.31 | 787 | 2,605 | 4,237 | 3.5 K to 4.2 K (+22.81 %) |
| Aug 12 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.33 | 500 | 1,666 | 3,450 | 3 K to 3.5 K (+16.95 %) |
| Aug 12 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.32 | 100 | 332 | 2,950 | 2.9 K to 3 K (+3.51 %) |
| Aug 12 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.34 | 100 | 334 | 2,850 | 2.8 K to 2.9 K (+3.64 %) |
| Aug 12 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.12 | 500 | 1,560 | 2,750 | 2.3 K to 2.8 K (+22.22 %) |
| Aug 12 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.15 | 250 | 788 | 2,250 | 2 K to 2.3 K (+12.50 %) |
| Aug 12 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.20 | 500 | 1,600 | 2,000 | 1.5 K to 2 K (+33.33 %) |
| Aug 12 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.25 | 500 | 1,625 | 1,500 | 1,000 to 1.5 K (+50.00 %) |
| Aug 12 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.27 | 500 | 1,635 | 1,000 | 500 to 1,000 (+100.00 %) |
| Aug 12 2009 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Buy | P | 3.30 | 500 | 1,650 | 500 | 0 to 500 |
| Dec 15 2008 | HRT | ARRHYTHMIA RESEARC ... | MARINOS E P | Director | Buy | P | 2.43 | 500 | 1,217 | 51,948 | 51.4 K to 51.9 K (+0.97 %) |
| Dec 15 2008 | HRT | ARRHYTHMIA RESEARC ... | MARINOS E P | Director | Buy | P | 2.48 | 500 | 1,242 | 51,448 | 50.9 K to 51.4 K (+0.98 %) |
| Dec 15 2008 | HRT | ARRHYTHMIA RESEARC ... | MARINOS E P | Director | Buy | P | 2.50 | 1,500 | 3,750 | 50,948 | 49.4 K to 50.9 K (+3.03 %) |
| Sep 16 2008 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Buy | P | 4.75 | 2,000 | 9,500 | 16,033 | 14 K to 16 K (+14.25 %) |
| Sep 16 2008 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Buy | P | 4.60 | 400 | 1,840 | 14,033 | 13.6 K to 14 K (+2.93 %) |
| Sep 16 2008 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Buy | P | 4.59 | 100 | 459 | 13,633 | 13.5 K to 13.6 K (+0.74 %) |
| Sep 16 2008 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Buy | P | 4.75 | 4,300 | 20,425 | 13,533 | 9.2 K to 13.5 K (+46.57 %) |
| Sep 15 2008 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Buy | P | 4.66 | 200 | 932 | 9,233 | 9 K to 9.2 K (+2.21 %) |
| Sep 15 2008 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Buy | P | 4.55 | 500 | 2,275 | 9,033 | 8.5 K to 9 K (+5.86 %) |
| Sep 15 2008 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Buy | P | 4.60 | 200 | 920 | 8,533 | 8.3 K to 8.5 K (+2.40 %) |
| Jan 04 2008 | HRT | ARRHYTHMIA RESEARC ... | WALTER PAUL | Director | Option Exercise | A | 7.15 | 10,000 | 71,500 | 20,000 | |
| Jan 04 2008 | HRT | ARRHYTHMIA RESEARC ... | TABIN JULIUS | Director | Option Exercise | A | 7.15 | 10,000 | 71,500 | 20,000 | |
| Jan 04 2008 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | President & CEO | Option Exercise | A | 7.15 | 9,500 | 67,925 | 9,500 | |
| Jan 04 2008 | HRT | ARRHYTHMIA RESEARC ... | Nolan Michael Francis | Chief Operating Off ... | Option Exercise | A | 7.15 | 7,500 | 53,625 | 17,500 | |
| Jan 04 2008 | HRT | ARRHYTHMIA RESEARC ... | MARINOS E P | Director | Option Exercise | A | 7.15 | 10,000 | 71,500 | 20,000 | |
| Jan 04 2008 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Option Exercise | A | 7.15 | 7,500 | 53,625 | 40,500 | |
| Jan 04 2008 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Option Exercise | A | 7.15 | 10,000 | 71,500 | 20,000 | |
| Aug 24 2007 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | Director | Sell | S | 12.82 | 6,000 | 76,938 | 15,000 | 21 K to 15 K (-28.57 %) |
| Aug 24 2007 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | Director | Sell | S | 13.00 | 800 | 10,400 | 21,000 | 21.8 K to 21 K (-3.67 %) |
| Aug 24 2007 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | Director | Sell | S | 13.10 | 700 | 9,170 | 21,800 | 22.5 K to 21.8 K (-3.11 %) |
| Aug 24 2007 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | Director | Sell | S | 13.15 | 500 | 6,575 | 22,500 | 23 K to 22.5 K (-2.17 %) |
| Aug 22 2007 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Buy | P | 9.25 | 2,100 | 19,425 | 8,333 | 6.2 K to 8.3 K (+33.69 %) |
| Aug 17 2007 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Buy | P | 9.24 | 2,900 | 26,796 | 6,233 | 3.3 K to 6.2 K (+87.01 %) |
| Apr 05 2007 | HRT | ARRHYTHMIA RESEARC ... | Chambers Medical Foundation | 10% Owner | Sell | S | 22.85 | 1,716 | 39,207 | 0 | 1.7 K to 0 (-100.00 %) |
| Apr 05 2007 | HRT | ARRHYTHMIA RESEARC ... | Chambers Medical Foundation | 10% Owner | Sell | S | 21.06 | 5,500 | 115,855 | 1,716 | 7.2 K to 1.7 K (-76.22 %) |
| Apr 05 2007 | HRT | ARRHYTHMIA RESEARC ... | Chambers Medical Foundation | 10% Owner | Sell | S | 21.05 | 5,000 | 105,254 | 7,216 | 12.2 K to 7.2 K (-40.93 %) |
| Dec 15 2006 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | President & CEO | Option Exercise | M | 9.86 | 10,000 | 98,600 | 0 | |
| Dec 15 2006 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | President & CEO | Sell | D | 29.00 | 4,700 | 136,300 | 23,000 | 27.7 K to 23 K (-16.97 %) |
| Dec 15 2006 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | President & CEO | Sell | D | 29.26 | 300 | 8,778 | 27,700 | 28 K to 27.7 K (-1.07 %) |
| Dec 12 2006 | HRT | ARRHYTHMIA RESEARC ... | Chambers Medical Foundation | 10% Owner | Sell | S | 26.70 | 12,500 | 333,710 | 12,226 | 24.7 K to 12.2 K (-50.55 %) |
| Dec 08 2006 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | President & CEO | Option Exercise | M | 2.00 | 18,000 | 36,000 | 0 | |
| Dec 08 2006 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | President & CEO | Sell | S | 26.50 | 3,000 | 79,500 | 18,000 | 21 K to 18 K (-14.29 %) |
| Dec 07 2006 | HRT | ARRHYTHMIA RESEARC ... | Chambers Medical Foundation | 10% Owner | Sell | S | 26.66 | 9,490 | 252,976 | 24,726 | 34.2 K to 24.7 K (-27.74 %) |
| Dec 07 2006 | HRT | ARRHYTHMIA RESEARC ... | Chambers Medical Foundation | 10% Owner | Sell | S | 27.07 | 15,500 | 419,625 | 34,216 | 49.7 K to 34.2 K (-31.18 %) |
| Dec 07 2006 | HRT | ARRHYTHMIA RESEARC ... | Chambers Medical Foundation | 10% Owner | Sell | S | 26.66 | 9,500 | 253,242 | 276,268 | 285.8 K to 276.3 K (-3.32 %) |
| Dec 07 2006 | HRT | ARRHYTHMIA RESEARC ... | Chambers Medical Foundation | 10% Owner | Sell | S | 27.07 | 15,500 | 419,625 | 285,768 | 301.3 K to 285.8 K (-5.14 %) |
| Dec 01 2006 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Sell | D | 24.08 | 10,000 | 240,848 | 35,216 | 45.2 K to 35.2 K (-22.12 %) |
| Aug 08 2006 | HRT | ARRHYTHMIA RESEARC ... | Chambers Jason Russell | Director | Option Exercise | A | 12.42 | 10,000 | 124,200 | 10,000 | |
| Apr 18 2006 | HRT | ARRHYTHMIA RESEARC ... | TABIN JULIUS | Director | Sell | D | 28.52 | 12,000 | 342,227 | 116,824 | 128.8 K to 116.8 K (-9.32 %) |
| Dec 21 2005 | HRT | ARRHYTHMIA RESEARC ... | GARRISON DAVID A | Chief Financial Off ... | Option Exercise | A | 9.86 | 8,000 | 78,880 | 33,000 | |
| Dec 21 2005 | HRT | ARRHYTHMIA RESEARC ... | MARINOS E P | Director | Option Exercise | A | 9.86 | 10,000 | 98,600 | 10,000 | |
| Dec 21 2005 | HRT | ARRHYTHMIA RESEARC ... | TABIN JULIUS | Director | Option Exercise | A | 9.86 | 10,000 | 98,600 | 10,000 | |
| Dec 21 2005 | HRT | ARRHYTHMIA RESEARC ... | ROUSE JAMES E | Chief Executive Off ... | Option Exercise | A | 9.86 | 10,000 | 98,600 | 28,000 | |
| Dec 21 2005 | HRT | ARRHYTHMIA RESEARC ... | WALTER PAUL | Director | Option Exercise | A | 9.86 | 10,000 | 98,600 | 10,000 | |
| Dec 10 2004 | HRT | ARRHYTHMIA RESEARC ... | CHAMBERS RUSSELL C | Director | Sell | S | 24.86 | 5,000 | 124,300 | 394,700 | 399.7 K to 394.7 K (-1.25 %) |
| Nov 17 2004 | HRT | ARRHYTHMIA RESEARC ... | CHAMBERS RUSSELL C | Director | Sell | S | 33.50 | 2,500 | 83,750 | 399,700 | 402.2 K to 399.7 K (-0.62 %) |
| Nov 17 2004 | HRT | ARRHYTHMIA RESEARC ... | CHAMBERS RUSSELL C | Director | Sell | S | 31.38 | 5,000 | 156,920 | 402,200 | 407.2 K to 402.2 K (-1.23 %) |
| Nov 17 2004 | HRT | ARRHYTHMIA RESEARC ... | CHAMBERS RUSSELL C | Director | Sell | S | 31.25 | 1,000 | 31,250 | 407,200 | 408.2 K to 407.2 K (-0.24 %) |
| Nov 17 2004 | HRT | ARRHYTHMIA RESEARC ... | CHAMBERS RUSSELL C | Director | Sell | S | 31.25 | 500 | 15,625 | 408,200 | 408.7 K to 408.2 K (-0.12 %) |
| Nov 17 2004 | HRT | ARRHYTHMIA RESEARC ... | CHAMBERS RUSSELL C | Director | Sell | S | 31.25 | 1,000 | 31,250 | 408,700 | 409.7 K to 408.7 K (-0.24 %) |
| Nov 17 2004 | HRT | ARRHYTHMIA RESEARC ... | CHAMBERS RUSSELL C | Director | Sell | S | 31.40 | 1,000 | 31,400 | 409,700 | 410.7 K to 409.7 K (-0.24 %) |
| Nov 17 2004 | HRT | ARRHYTHMIA RESEARC ... | CHAMBERS RUSSELL C | Director | Sell | S | 31.52 | 2,500 | 78,800 | 410,700 | 413.2 K to 410.7 K (-0.61 %) |
| Nov 17 2004 | HRT | ARRHYTHMIA RESEARC ... | CHAMBERS RUSSELL C | Director | Sell | S | 31.45 | 2,500 | 78,625 | 413,200 | 415.7 K to 413.2 K (-0.60 %) |